SCHEMBL17876133

SCHEMBL17876133

CC1(C)Oc2cc(-c3ccc4c(c3)oc3ccccc34)ccc2-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2O1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
MAPT P10636 4/20 0.32
KMT2A Q03164 4/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 2/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
AHR P35869 1/20 0.32
ACACA Q13085 2/20 0.32
PGR P06401 1/20 0.32
MEN1 O00255 3/20 0.32
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
AKT1 P31749 1/20 0.31
AKT2 P31751 1/20 0.31
AKT3 Q9Y243 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876172 1.00 HCRTR1 (0.33) HCRTR1MMP12MMP13MAPTKMT2A
SCHEMBL17876197 0.96 HCRTR1 (0.36) HCRTR1MMP12MMP13MAPTKMT2A
SCHEMBL17876177 0.94 PLA2G2A (0.34) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL17876153 0.94 PLA2G2A (0.34) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL17876139 0.90 MMP12 (0.38) HCRTR1MMP12MMP13MAPTKMT2A
SCHEMBL17876159 0.90 MMP12 (0.38) HCRTR1MMP12MMP13MAPTKMT2A
SCHEMBL17876154 0.90 KDM4E (0.32) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL17876174 0.90 KDM4E (0.32) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL17876205 0.89 PLA2G2A (0.36) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL17876134 0.89 AHR (0.40) HCRTR1MMP12MMP13MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 HCRTR1 214/4885MMP12 4056/4885MMP13 3950/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 HCRTR1 214/4885MMP12 4056/4885MMP13 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.